Arcus Biosciences
RCUS
Arcus Biosciences (RCUS) - Cash on Hand
Cash on Hand as of December 2023 : $0.75 B
According to Arcus Biosciences
's latest financial reports the company has $0.75 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arcus Biosciences - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.75 B | -24.78% |
| 2022-12-31 | $1.00 B | 102.2% |
| 2021-12-31 | $0.49 B | -31.52% |
| 2020-12-31 | $0.72 B | 287.02% |
| 2019-12-31 | $0.18 B | -26.61% |
| 2018-12-31 | $0.25 B | 46.01% |
| 2017-12-31 | $0.17 B | 77.66% |
| 2016-12-31 | $98.89 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -72.57% | 🇺🇸 USA |